B-Raf inhibitor 1 Size:25mg Mutations in this gene result

Mutations in this gene result in oculocutaneous albinism

researchers can better understand their intricate roles and potential as therapeutic targets

Cell counter

Swissprot No Q07812 Gene Accession BC014175 WB Predicted band size 21 kDa WB Positive control WB Recommended dilution 5000-20000 IHC predicted cell location Predicted cell location: Cytoplasm IHC positive control Positive control: Human cervical cancer IHC Recommed dilution Recommended dilution: 50-200 Storage

Swissprot No Q15021 Gene Accession BC028182 WB Predicted band size 157 kDa WB Positive control WB Recommended dilution 1000-5000 IHC predicted cell location Predicted cell location: Cytoplasm and Nucleus IHC positive control Positive control: Human gastric cancer IHC Recommed dilution Recommended dilution: 50-200 Storage

B-Raf inhibitor 1 Size:25mg Mutations in this gene resultDescription B Raf inhibitor 1 (Compound 13) is a type IIA Raf inhibitor which bind to the DFG out conformation with ki of 1 nM,1 nM,and 0. 3 nM for B Raf(WT), B Raf(V600E) and C Raf, respectively. For research use only. We do not sell to patients. Specification Formal Name N1 (4 chlorophenyl) 6 methyl N5 [3 (9H purin 6 yl) 2 pyridinyl] 1,5 isoquinolinediamine, dihydrochloride CAS Number 1191385 19 9 Molecular Formula C26H19ClN8 2HCl Formula Weight